tradmap

USNA Earnings USANA HEALTH SCIENCES INC

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
$0 $3 $6 2016 2017 2018 2019 2021 2022 2022 2023 2024 2026
EPS
Revenue (annual)
$0 $595M $1B 2016 2017 2018 2019 2021 2022 2022 2023 2024 2026
Revenue
Net income (annual)
$0 $63M $126M 2016 2017 2018 2019 2021 2022 2022 2023 2024 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $1 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $125M $250M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q2 '26
Revenue
Net income (quarterly)
-$21M -$2M $17M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q2 '26
Net income

Reported EPS history

1–60 of 60
Q2 20262026-07-04-1.162026-08-1310-Q
Q1 20262026-04-040.412026-05-1210-Q
Q4 2025 (derived)2026-01-03-0.072026-03-1610-K
FY 20252026-01-030.582026-03-1610-K
Q3 20252025-09-27-0.362025-11-0510-Q
Q2 20252025-06-280.522025-08-0510-Q
Q1 20252025-03-290.492025-05-0610-Q
Q4 2024 (derived)2024-12-280.232025-03-1210-K
FY 20232024-12-282.192025-03-1210-K
Q3 20242024-09-280.562024-11-0510-Q
Q2 20242024-06-290.542024-08-0610-Q
Q1 20242024-03-300.862024-05-0710-Q
Q4 2023 (derived)2023-12-300.872024-02-2710-K
FY 20232023-12-303.302024-02-2710-K
Q3 20232023-09-300.592023-11-0710-Q
Q2 20232023-07-010.892023-08-0810-Q
Q1 20232023-04-010.952023-05-0910-Q
Q4 2022 (derived)2022-12-310.662023-02-2810-K
FY 20222022-12-313.592023-02-2810-K
Q3 20222022-10-010.782022-11-0810-Q
Q2 20222022-07-021.002022-08-0910-Q
Q1 20222022-04-021.152022-05-1110-Q
Q4 2022 (derived)2022-01-011.052022-03-0110-K
FY 20222022-01-015.732022-03-0110-K
Q3 20222021-10-021.362021-11-1010-Q
Q2 20222021-07-031.872021-08-1110-Q
Q1 20212021-04-031.452021-05-1110-Q
Q4 2020 (derived)2021-01-021.872021-03-0210-K
FY 20202021-01-025.862021-03-0210-K
Q3 20202020-09-261.442020-11-0310-Q
Q2 20202020-06-271.322020-08-0410-Q
Q1 20202020-03-281.232020-05-0510-Q
Q4 20192019-12-281.412020-02-2510-K
FY 20192019-12-284.412020-02-2510-K
Q3 20192019-09-281.092019-11-0510-Q
Q2 20192019-06-290.912019-08-0610-Q
Q1 20192019-03-301.012019-05-0710-Q
Q4 20182018-12-291.322019-02-2610-K
FY 20182018-12-295.122019-02-2610-K
Q3 20182018-09-291.242018-11-0710-Q
Q2 20182018-06-301.362018-08-0810-Q
Q1 20182018-03-311.192018-05-0910-Q
Q4 20172017-12-30-0.242018-02-2810-K
FY 20172017-12-302.532018-02-2810-K
Q3 20172017-09-300.972017-11-0810-Q
Q2 20172017-07-010.932017-08-0910-Q
Q1 20172017-04-010.862017-05-1010-Q
Q4 20162016-12-310.872017-03-0110-K
FY 20162016-12-313.992017-03-0110-K
Q3 20162016-10-011.202016-11-0910-Q
Q2 20162016-07-021.032016-08-0910-Q
Q1 20162016-04-020.892016-05-1110-Q
Q4 20152016-01-020.922016-03-0110-K
FY 20152016-01-023.592016-03-0110-K
Q3 20152015-10-030.962015-11-1210-Q
Q2 20152015-07-040.962015-08-1210-Q
Q1 20152015-04-040.752015-05-1310-Q
Q4 20142015-01-030.822015-03-1710-K
FY 20142015-01-032.802015-03-1710-K
Q3 20142014-09-270.732014-11-0610-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.